Tapewire

NYSE · USD

HAE

HAEMONETICS CORP

Export transactions ↓
Tapewire entity
3953
SEC CIK
0000313143
Parsed reports
416

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202510
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
July 21, 2020 Filed Jul 22, 2020 21:17 UTC GrantCommon Stock 1,983 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-021977 · form4.xml · nonDerivative · entry 1

COYLE MICHAEL J · CIK 0001233311 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,461

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 21:15 UTC GrantCommon Stock 1,983 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-021975 · form4.xml · nonDerivative · entry 1

BURZIK CATHERINE M · CIK 0001261141 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,738

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
July 21, 2020 Filed Jul 22, 2020 21:11 UTC GrantCommon Stock 1,983 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-021973 · form4.xml · nonDerivative · entry 1

ABERNATHY ROBERT E · CIK 0001222888 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,048

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 30, 2020 Filed Jul 2, 2020 20:20 UTC
Simon, ChristopherDirector · President & CEO
SaleCommon Stock 5,084 $87.79 $446,324.36
Disclosure

SEC source: 0001127602-20-020895 · form4.xml · nonDerivative · entry 1

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,310

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 22:19 UTC
Basil Michelle LEVP and General Counsel
SaleCommon Stock 1,300 $92.14 $119,782.00
Disclosure

SEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 6

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,173

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.24, inclusive.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 22:19 UTC
Basil Michelle LEVP and General Counsel
SaleCommon Stock 6,961 $91.34 $635,817.74
Disclosure

SEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 5

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,473

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.93, inclusive.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 22:19 UTC
Basil Michelle LEVP and General Counsel
SaleCommon Stock 5,175 $90.32 $467,406.00
Disclosure

SEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 4

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,434

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.93 to $90.93, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
SaleCommon Stock 6,869 $91.53 $628,719.57
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 6

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,487

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 22:16 UTC
Burke William P. Mr.EVP, Chief Financial Officer
SaleCommon Stock 1,209 $92.09 $111,336.81
Disclosure

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 6

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,498

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.97 to $92.24, inclusive.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 22:16 UTC
Burke William P. Mr.EVP, Chief Financial Officer
SaleCommon Stock 6,146 $91.38 $561,621.48
Disclosure

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 5

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,707

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.95 to $91.95, inclusive.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 22:16 UTC
Burke William P. Mr.EVP, Chief Financial Officer
SaleCommon Stock 5,259 $90.36 $475,203.24
Disclosure

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 4

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,853

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.94 to $90.94, inclusive. The reporting person undertakes to provide to Haemonetics Corporation ("Haemonetics"), any security holder of Haemonetics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (6) through (8) to this Form 4.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 16, 2020 Filed Jun 16, 2020 21:55 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 3,040 $91.53 $278,251.20
Disclosure

SEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 5

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,849

F4 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 22:19 UTC
Basil Michelle LEVP and General Counsel
SaleCommon Stock 10,578 $87.71 $927,796.38
Disclosure

SEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 3

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,609

F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 2,889 $0.00 Strike: $41.64 $0.00
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · derivative · entry 7

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,890

Underlying: Common Stock · 2,889 shares

Expires 2024-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
SaleCommon Stock 4,005 $90.00 $360,450.00
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 5

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,356

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
Exercise / conversionCommon Stock 2,889 $41.64 $120,297.96
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 4

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,361

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
SaleCommon Stock 4,417 $87.71 $387,415.07
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 3

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,472

F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 22:16 UTC
Burke William P. Mr.EVP, Chief Financial Officer
SaleCommon Stock 9,720 $87.71 $852,541.20
Disclosure

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 3

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,112

F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:55 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 1,282 $87.71 $112,444.22
Disclosure

SEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 4

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,889

F5 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F5 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:55 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 92 $87.16 $8,018.72
Disclosure

SEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 3

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,171

F4 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 21:51 UTC
Simon, ChristopherDirector · President & CEO
SaleCommon Stock 45,723 $87.71 $4,010,364.33
Disclosure

SEC source: 0001127602-20-019787 · form4.xml · nonDerivative · entry 3

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 370,394

F4 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F4 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the PSUs reported above on June 12, 2020. This sale is mandated by the Issuer's election under its 2005 Long-Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 22:19 UTC
Basil Michelle LEVP and General Counsel
SaleCommon Stock 203 $89.29 $18,125.87
Disclosure

SEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 2

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,187

F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 22:19 UTC
Basil Michelle LEVP and General Counsel
GrantCommon Stock 24,014 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-019791 · form4.xml · nonDerivative · entry 1

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,390

F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
SaleCommon Stock 111 $89.29 $9,911.19
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 2

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,889

F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:53 UTC
Scanlan JacquelineSVP, Global Human Resources
GrantCommon Stock 11,286 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-019788 · form4.xml · nonDerivative · entry 1

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,000

F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 22:16 UTC
Burke William P. Mr.EVP, Chief Financial Officer
SaleCommon Stock 197 $89.29 $17,590.13
Disclosure

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 2

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,832

F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 22:16 UTC
Burke William P. Mr.EVP, Chief Financial Officer
GrantCommon Stock 22,334 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-019790 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,029

F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:55 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 42 $82.29 $3,456.18
Disclosure

SEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 2

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,263

F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:55 UTC
Goldstein DanVP, Corporate Controller
GrantCommon Stock 4,322 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-019789 · form4.xml · nonDerivative · entry 1

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,305

F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:51 UTC
Simon, ChristopherDirector · President & CEO
SaleCommon Stock 1,294 $89.29 $115,541.26
Disclosure

SEC source: 0001127602-20-019787 · form4.xml · nonDerivative · entry 2

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 416,117

F3 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F3 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain RSUs previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 12, 2020 Filed Jun 16, 2020 21:51 UTC
Simon, ChristopherDirector · President & CEO
GrantCommon Stock 102,064 $0.00 $0.00
Disclosure

SEC source: 0001127602-20-019787 · form4.xml · nonDerivative · entry 1

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 417,411

F1 · kind: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F1 · shares: Represents shares earned from a performance share unit ("PSU") award granted to the reporting person on June 6, 2017, based on the issuer's total shareholder return relative to that of the companies comprising a blended index of the S&P MidCap 400 and S&P SmallCap 600 for the performance period from June 6, 2017 to June 5, 2020, as certified by the Compensation Committee of the Board of Directors on June 12, 2020.

F2 · balance_after: This number includes unvested restricted stock units ("RSUs") previously reported.

Read SEC document
June 09, 2020 Filed Jun 10, 2020 22:04 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 187 $97.19 $18,174.53
Disclosure

SEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 4

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,983

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 22:04 UTC
Goldstein DanVP, Corporate Controller
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative 1,106 $0.00 Strike: $41.64 $0.00
Disclosure

SEC source: 0001127602-20-019382 · form4.xml · derivative · entry 5

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,107

Underlying: Common Stock · 1,106 shares

Expires 2024-06-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 22:04 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 1,106 $99.09 $109,593.54
Disclosure

SEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 3

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,170

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 22:04 UTC
Goldstein DanVP, Corporate Controller
Exercise / conversionCommon Stock 1,106 $41.64 $46,053.84
Disclosure

SEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 2

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,276

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · kind: Transaction pursuant to an existing 10b5-1 trading plan.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 22:04 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 83 $97.03 $8,053.49
Disclosure

SEC source: 0001127602-20-019382 · form4.xml · nonDerivative · entry 1

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,170

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 21:59 UTC
Scanlan JacquelineSVP, Global Human Resources
SaleCommon Stock 324 $97.03 $31,437.72
Disclosure

SEC source: 0001127602-20-019381 · form4.xml · nonDerivative · entry 1

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,714

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 21:57 UTC
Basil Michelle LEVP and General Counsel
SaleCommon Stock 687 $97.03 $66,659.61
Disclosure

SEC source: 0001127602-20-019379 · form4.xml · nonDerivative · entry 1

Basil Michelle L · CIK 0001699629 · EVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,376

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 21:54 UTC
Burke William P. Mr.EVP, Chief Financial Officer
SaleCommon Stock 639 $97.03 $62,002.17
Disclosure

SEC source: 0001127602-20-019376 · form4.xml · nonDerivative · entry 1

Burke William P. Mr. · CIK 0001682069 · EVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,695

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
June 08, 2020 Filed Jun 10, 2020 21:52 UTC
Simon, ChristopherDirector · President & CEO
SaleCommon Stock 2,920 $97.03 $283,327.60
Disclosure

SEC source: 0001127602-20-019374 · form4.xml · nonDerivative · entry 1

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 315,347

F1 · kind: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F1 · shares: Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of certain restricted stock units ("RSUs") previously reported in Table I following the date of grant. This sale is mandated by the Issuer's election under its 2005 Long Term Incentive Compensation Plan (as amended) to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
May 18, 2020 Filed May 19, 2020 23:06 UTC
Simon, ChristopherDirector · President & CEO
GrantNon-qualified Stock Option (Right to Buy) · Derivative 49,105 $0.00 Strike: $103.37 $0.00
Disclosure

SEC source: 0001127602-20-017282 · form4.xml · derivative · entry 3

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 49,105

Underlying: Common Stock · 49,105 shares

Expires 2027-05-18

F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document
May 18, 2020 Filed May 19, 2020 23:06 UTC
Simon, ChristopherDirector · President & CEO
GrantCommon Stock 14,510 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-017282 · form4.xml · nonDerivative · entry 2

Simon, Christopher · CIK 0001674993 · Director · President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 318,267

F3 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F3 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F4 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F2 · balance_after: This number includes unvested RSUs previously reported as well as 193 shares acquired by the reporting person under the Issuer's 2007 Employee Stock Purchase Plan (as amended) on April 30, 2020.

Read SEC document
May 18, 2020 Filed May 19, 2020 22:10 UTC
Goldstein DanVP, Corporate Controller
GrantNon-qualified Stock Option (Right to Buy) · Derivative 1,841 $0.00 Strike: $103.37 $0.00
Disclosure

SEC source: 0001127602-20-017278 · form4.xml · derivative · entry 4

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,841

Underlying: Common Stock · 1,841 shares

Expires 2027-05-18

F6 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document
May 18, 2020 Filed May 19, 2020 22:10 UTC
Goldstein DanVP, Corporate Controller
GrantCommon Stock 544 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-017278 · form4.xml · nonDerivative · entry 3

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,253

F4 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F4 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F5 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
May 18, 2020 Filed May 19, 2020 22:10 UTC
Goldstein DanVP, Corporate Controller
SaleCommon Stock 101 $101.72 $10,273.72
Disclosure

SEC source: 0001127602-20-017278 · form4.xml · nonDerivative · entry 2

Goldstein Dan · CIK 0001722327 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,709

F3 · kind: Sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
May 18, 2020 Filed May 19, 2020 21:51 UTC
Llorens JosepSVP, Global Manufacturing
GrantNon-qualified Stock Option (Right to Buy) · Derivative 5,728 $0.00 Strike: $103.37 $0.00
Disclosure

SEC source: 0001127602-20-017270 · form4.xml · derivative · entry 3

Llorens Josep · CIK 0001750812 · SVP, Global Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,728

Underlying: Common Stock · 5,728 shares

Expires 2027-05-18

F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document
May 18, 2020 Filed May 19, 2020 21:51 UTC
Llorens JosepSVP, Global Manufacturing
GrantCommon Stock 1,692 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-017270 · form4.xml · nonDerivative · entry 2

Llorens Josep · CIK 0001750812 · SVP, Global Manufacturing

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,355

F3 · kind: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F3 · shares: The securities awarded are in the form of RSUs issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F4 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F2 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
May 18, 2020 Filed May 19, 2020 21:42 UTC
Lingamneni AnilaEVP, Chief Technology Officer
GrantNon-qualified Stock Option (Right to Buy) · Derivative 4,092 $0.00 Strike: $103.37 $0.00
Disclosure

SEC source: 0001127602-20-017268 · form4.xml · derivative · entry 2

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,092

Underlying: Common Stock · 4,092 shares

Expires 2027-05-18

F4 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document
May 18, 2020 Filed May 19, 2020 21:42 UTC
Lingamneni AnilaEVP, Chief Technology Officer
GrantCommon Stock 1,209 Not disclosed Not disclosed
Disclosure

SEC source: 0001127602-20-017268 · form4.xml · nonDerivative · entry 1

Lingamneni Anila · CIK 0001808414 · EVP, Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,390

F1 · kind: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F1 · shares: The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation 2019 Long-Term Incentive Compensation Plan. The RSUs vest in annual increments of 25% beginning on the first anniversary of the date of grant.

F2 · price: Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

F3 · balance_after: This number includes unvested RSUs previously reported.

Read SEC document
May 18, 2020 Filed May 19, 2020 21:34 UTC
Scanlan JacquelineSVP, Global Human Resources
GrantNon-qualified Stock Option (Right to Buy) · Derivative 5,319 $0.00 Strike: $103.37 $0.00
Disclosure

SEC source: 0001127602-20-017266 · form4.xml · derivative · entry 3

Scanlan Jacqueline · CIK 0001713517 · SVP, Global Human Resources

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,319

Underlying: Common Stock · 5,319 shares

Expires 2027-05-18

F5 · derivative.exercise_date: Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.